The goal of the Cincinnati Center of Excellence in Molecular Hematology (CCEMH) is to understand and correct at the molecular level diseases affecting cells derived from hematopoietic stem cells.
CCEMH facilitates center members to progress toward this goal by fostering interdisciplinary, collaborative approaches, using state-of-the-art molecular and cell biology methods along with timely and rational application of translational studies in the clinical setting.
The Xenotransplant and Genome Editing Core, Gene Delivery Core, and Single Cell Characterization and Procurement Core provide fee-for-service offerings to researchers. The goal of the Enrichment Core is to facilitate scientific exchange and sharing of techniques and resources.
The CCEMH is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and is co-led by Yi Zheng, PhD, and Daniel Starczynowski, PhD.
The CCEMH is a member of the Cooperative Centers of Excellence in Hematology (CCEH).